Contineum Therapeutics, Inc. Class A Financial Overview
Contineum Therapeutics, Inc. Class A's market cap is currently $350.52M. The company's EPS TTM is $-0.62; its P/E ratio is ―; Contineum Therapeutics, Inc. Class A is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Currency in USD
Contineum Therapeutics, Inc. Class A Earnings and Revenue History
